Request Discount

Companion Diagnostics Market (Technology - Polymerase Chain Reaction, In Situ Hybridization, Immunohistochemistry, Next-generation Sequencing, and Other Technologies; Indications - Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma, and Other Indications; End-users - Pharmaceutical, Biopharmaceutical Companies, Reference Laboratories, and Other End-users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0514

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Companion Diagnostics Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Companion Diagnostics Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Companion Diagnostics Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on companion diagnostics market provides in-depth analysis of segments and sub-segments in the global as well as regional companion diagnostics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional companion diagnostics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global companion diagnostics market. According to the report, the global companion diagnostics market is projected to grow at a CAGR of 19.30% over the forecast period of 2019-2025.


Segment Covered

The report on global companion diagnostics market covers segments such as technology, indications, and end-users. On the basis of technology, the sub-markets include polymerase chain reaction, in situ hybridization, immunohistochemistry, next-generation sequencing, and other technologies. On the basis of indications, the sub-markets include lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, and other indications. On the basis of end-users, the sub-markets include pharmaceutical, biopharmaceutical companies, reference laboratories, and other end-users.

Global Companion Diagnostics Market


Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories Inc., Roche Holding AG, Agilent Technologies Inc., Biomerieux SA, QIAGEN N.V., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Danaher Corporation, Myriad Genetics Inc., and Genomic Health, Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the companion diagnostics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount